Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-08

Clinical Trial Update: Oral or Topical Catechins for Radiation Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating oral or topical catechins for radiation dermatitis is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Catechins (catechin)

Snippet

Sponsor: CARLOS FRANCISCO SAAVEDRA GARCIA | Conditions: Radiation Dermatitis Acute, Radiation Dermatitis | Phase 3 | Status: ENROLLING_BY_INVITATION